Incidence and associations of acute renal failure complicating high‐dose intravenous immunoglobulin therapy

Abstract

In a formal study, we have identified increasing age, pretreatment renal impairment and diabetes mellitus as risk factors for the development of intravenous immunoglobulin-induced renal failure. Identification of these characteristics in potential recipients should alert clinicians to the associated increased risk of this serious complication.